In the future, an increasing number of patients with severe infection should benefit from several new therapies which make use of biological response modifiers. However, the complexity of these new therapies demands an exhaustive knowledge of their mode of action, biological repurcussions and pharmaceutical design in order to assess their clinical potential. This text provides a review of recent progress in anti-cytokine, anti-endotoxin, anti-neutrophil and anti-arachidonic therapies. It includes an overview of the basic cellular and molecular mechanisms involved as well as an update of current experience with human clinical trials.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Zubal-Books, Since 1961, Cleveland, OH, Etats-Unis
Etat : Good. *Price HAS BEEN REDUCED by 10% until Monday, June 22 (weekend SALE item)* 188 pp., Hardcover, ex library, else text clean and binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country. N° de réf. du vendeur ZB897144
Quantité disponible : 1 disponible(s)